ClinicalTrials.gg
CompletedNCT07884916Updated Oct 21, 2026

Topical Nitroglycerin Versus Lateral Internal Sphincterotomy for Chronic Anal Fissure

An interventional study of Topical 0.2% Glyceryl Trinitrate (Nitroglycerin) Ointment and Lateral Internal Sphincterotomy in Chronic Anal Fissure, sponsored by Sheikh Zayed Federal Postgraduate Medical Institute. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Sheikh Zayed Federal Postgraduate Medical Institute · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2026, registered Oct 2026).
Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Chronic anal fissure is a tear in the lining of the anal canal that can cause pain during and after defecation. This randomized controlled trial will compare topical 0.2% nitroglycerin ointment with lateral internal sphincterotomy in adults with chronic anal fissure. A total of 72 eligible participants will be allocated to one of two treatment groups. The nitroglycerin group will receive topical treatment twice daily for six weeks, while the surgical group will undergo lateral internal sphincterotomy. Participants will be assessed at Day 7 and Weeks 2, 3, 4 and 8. The study will compare the time required for pain relief and complete fissure healing between the two treatment groups.

Read the detailed description

This is a randomized controlled trial to compare topical nitroglycerin and lateral internal sphincterotomy in patients aged 18-65 years with clinically diagnosed chronic anal fissure persisting for more than six weeks.

Eligible participants presenting to the Department of General Surgery and Surgical Oncology, Unit-2, Shaikh Zayed Hospital, Lahore, will be assessed against predefined inclusion and exclusion criteria. Following informed written consent, participants will be allocated to one of two groups using the lottery method described in the study protocol.

Group A will receive 0.2% topical glyceryl trinitrate (nitroglycerin) ointment in a liposomal base, applied twice daily for six weeks. Group B will undergo standard open lateral internal sphincterotomy.

Follow-up assessments will take place on Day 7 and at Weeks 2, 3, 4 and 8. Pain will be measured using the 10-point Visual Analogue Scale. Clinical examination will assess fissure healing.

Time to pain relief is defined in the protocol as the number of days from treatment initiation until the VAS score is 3 or less at two consecutive follow-up visits. Time to healing is defined as the number of days from treatment initiation until complete epithelialization, with no bleeding and no pain during defecation, confirmed by clinical examination.

The study will compare pain-relief time and healing time between the two treatment groups. Data will be analyzed using SPSS, with independent-samples t-tests or Mann-Whitney U tests for continuous outcomes as appropriate, and chi-square or Fisher's exact tests for categorical outcomes.

02

Conditions studied

  • Chronic Anal Fissure

Browse trials for

Keywords

  • Anal Fissure
  • Chronic anal fissure
  • Nitroglycerin
  • Glyceryl Trinitrate
  • Pain Relief
  • Fissure Healing
  • Lateral internal sphincterotomy
  • Randomized controlled trial
03

In context

Fissure in Ano

80 studies on the registry are indexed under Fissure in Ano; 14 are open to participants now.

This study's enrollment of 72 is below the median of 99 across 62 interventional studies indexed under Fissure in Ano.

Browse Fissure in Ano studies →

Lead sponsor

Sheikh Zayed Federal Postgraduate Medical Institute is the lead sponsor of 14 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-65 years. Both male and female participants. Clinically diagnosed chronic anal fissure persisting for more than six weeks. No prior surgical treatment for anal fissure. Able to comply with the follow-up schedule.

Exclusion criteria

Exclusion Criteria:

  • Acute anal fissure of less than six weeks' duration. Previous lateral internal sphincterotomy or anorectal surgery. Current use of topical glyceryl trinitrate or calcium channel blockers. Crohn's disease or tuberculosis. Perianal abscess or fistula. Grade III-IV hemorrhoids. Pregnancy. Known hypersensitivity to nitroglycerin. Inability or unwillingness to comply with follow-up. Failure to provide informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Topical Nitroglycerin Group

    Topical 0.2% glyceryl trinitrate ointment in a liposomal base, applied to the anoderm twice daily for six weeks.

    Drug: Topical 0.2% Glyceryl Trinitrate (Nitroglycerin) Ointment

  • Active comparator
    Lateral Internal Sphincterotomy

    Standard open lateral internal sphincterotomy, as described in the approved study protocol.

    Procedure: Lateral Internal Sphincterotomy

Interventions

  • Topical 0.2% glyceryl trinitrate (nitroglycerin) ointment applied locally twice daily for 6 weeks for the treatment of chronic anal fissure.

  • ProcedureLateral Internal Sphincterotomy

    Lateral internal sphincterotomy performed surgically for the treatment of chronic anal fissure.

06

What researchers measure

Primary outcomes

  1. Time to Pain Relief

    Number of days from initiation of treatment until the participant's Visual Analogue Scale pain score is 3 or less at two consecutive follow-up visits.

    Time frame: From treatment initiation through the final planned follow-up at Week 8.

  2. Time to Complete Healing of Chronic Anal Fissure

    Number of days from initiation of treatment until complete epithelialization of the fissure, with no bleeding and no pain during defecation, confirmed by clinical examination.

    Time frame: From treatment initiation through the final planned follow-up at Week 8.

07

Study locations

1 site
  • Shaikh Zayed Hospital, General Surgery and Surgical Oncology, Unit-2
    Lahore, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Patient-level surgical and clinical data are confidential. Sharing them requires appropriate de-identification, safeguards, and compliance with institutional ethics approval and applicable consent requirements.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07884916
Lead sponsor
Sheikh Zayed Federal Postgraduate Medical Institute
Responsible party
Zaigham Jameel (Speciality Registrar (SPR) / Postgraduate Resident (PGR), Sheikh Zayed Federal Postgraduate Medical Institute) — Principal investigator
First posted
Oct 21, 2026
Start date
Jun 15, 2026
Primary completion
Sep 14, 2026
Completion
Sep 14, 2026
Last update
Oct 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Topical Dosage Form

Start the discussion